Brochure
11 Nov 2023
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
PDF 154 kB
Content provided by our supplier
Somai Pharmaceuticals
-
PT -
2022On CPHI since
-
1Certificates
-
25 - 49Employees
Company types
Primary activities
Other Content from Somai Pharmaceuticals (2)
-
News SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFARMED.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance